Name: UMIN ID:
Unique ID issued by UMIN | UMIN000033565 |
---|---|
Receipt number | R000038279 |
Scientific Title | Kyoto Trial to Evaluate the Safety and Efficacy of Tacrolimus in the iPSC-based Therapy for Parkinson's Disease |
Date of disclosure of the study information | 2018/07/31 |
Last modified on | 2023/08/04 09:39:58 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/07/30 22:35:52 | ||
2 | Update | 2018/07/30 22:40:36 | Interventions/Control_1 |
|
3 | Update | 2018/07/31 10:08:58 | TEL TEL TEL |
|
4 | Update | 2018/07/31 10:25:33 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2018/07/31 10:34:40 | Key inclusion criteria Key inclusion criteria |
|
6 | Update | 2018/07/31 10:50:51 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
7 | Update | 2018/07/31 10:52:39 | Primary outcomes |
|
8 | Update | 2018/07/31 10:58:12 | Name of person sending information |
|
9 | Update | 2018/07/31 10:59:41 | Date of disclosure of the study information |
|
10 | Update | 2018/08/02 20:37:17 | Recruitment status |
|
11 | Update | 2019/09/12 22:31:05 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of secondary funder(s) Name of secondary funder(s) Organization Organization Address Address Tel |
|
12 | Update | 2019/09/12 22:40:17 | Last name of contact person Last name of contact person TEL TEL Name of secondary funder(s) Name of secondary funder(s) |
|
13 | Update | 2019/09/12 22:44:39 | TEL |
|
14 | Update | 2019/09/12 22:48:14 | Name of person sending information |
|
15 | Update | 2019/09/13 19:53:53 | TEL TEL TEL |
|
16 | Update | 2019/09/13 19:55:42 | Recruitment status Date of IRB Last follow-up date |
|
17 | Update | 2020/08/10 12:59:43 | Last follow-up date |
|
18 | Update | 2021/02/06 20:40:53 | Interventions/Control_1 Interventions/Control_1 |
|
19 | Update | 2022/01/29 16:40:48 | Recruitment status |
|
20 | Update | 2023/08/04 09:39:58 | Number of participants that the trial has enrolled |